Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability.
The relationship of age, function, and psychological distress in multiple sclerosis.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Functional outcomes associated with expiratory muscle strength training: Narrative review.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
Quality of life in patients with multiple sclerosis.
Cytomegalovirus and multiple sclerosis risk.
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
354
355
356
357
358
359
360
361
362
…
next ›
last »